Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
19 April 2024
|
m 00:36 | Esophageal squamous cell carcinoma 3 changes history +27 [Jwarner (3×)] | |||
m |
|
00:36 (cur | prev) -1 Jwarner talk contribs →Nivolumab monotherapy {{#subobject:10ee99|Regimen=1}} | |||
m |
|
00:35 (cur | prev) -1 Jwarner talk contribs →Regimen {{#subobject:d1dde0|Variant=1}} | |||
m |
|
00:35 (cur | prev) +29 Jwarner talk contribs →Camrelizumab monotherapy {{#subobject:c701c3|Regimen=1}} |
m 00:29 | Non-small cell lung cancer, nonsquamous diffhist -39 Jwarner talk contribs →Regimen variant #2, 5/500 x 4, then maintenance pem x 2y {{#subobject:1mwjm3|Variant=1}} |
14 April 2024
|
m 17:29 | Non-small cell lung cancer, nonsquamous 2 changes history +78 [Jwarner (2×)] | |||
m |
|
17:29 (cur | prev) +45 Jwarner talk contribs →Maintenance after first-line therapy | |||
m |
|
17:28 (cur | prev) +33 Jwarner talk contribs →Consolidation after definitive therapy for inoperable disease |